الصفحة الرئيسية>>Histone H3K9Ac (1-24) (human, mouse, rat, porcine, bovine) (trifluoroacetate salt)

Histone H3K9Ac (1-24) (human, mouse, rat, porcine, bovine) (trifluoroacetate salt) (Synonyms: ARTKQTAR-K(Ac)-STGGKAPRKQLATKA, H-Ala-Arg-Thr-Lys-Gln-Thr-Ala-Arg-Lys(Ac)-Ser-Thr-Gly-Gly-Lys-Ala-Pro-Arg-Lys-Gln-Leu-Ala-Thr-Lys-Ala-OH, Histone H3 (1-24) (Lys9ac), Lys(Ac)9-Histone H3 (1-24))

رقم الكتالوجGC40113

Histone H3K9Ac (1-24) is a peptide fragment that corresponds to amino acid residues 2-25 of the human histone H3 sequence.

Products are for research use only. Not for human use. We do not sell to patients.

Histone H3K9Ac (1-24) (human, mouse, rat, porcine, bovine) (trifluoroacetate salt) التركيب الكيميائي

الحجم السعر المخزون الكميّة
1mg
341٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Histone H3K9Ac (1-24) is a peptide fragment that corresponds to amino acid residues 2-25 of the human histone H3 sequence. Acetylation of histone H3 at lysine 9 is associated with active gene transcription and can recruit the super elongation complex to chromatin through direct binding with the AF9 and ENL subunits. It increases at the IFN-β promoter in HeLa cells upon infection with Sendai virus. Acetylation of histone H3 at lysine 9 decreases following induction of DNA damage in HeLa and U2OS cells.

مراجعات

Review for Histone H3K9Ac (1-24) (human, mouse, rat, porcine, bovine) (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Histone H3K9Ac (1-24) (human, mouse, rat, porcine, bovine) (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.